Keywords: Pfizer, Xalkori, Crizotinib, Abbott Labs, Companion diagnstoice NSCLC, USA, FDA

US FDA approves Pfizer lung cancer drug Xalkori and companion diagnostic from Abbott

Article | 30 August 2011

Print This

The US Food and Drug Administration has approved global drugs behemoth Pfizer’s (NYSE: PFE) Xalkori (crizotinib) to treat ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in